Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G T John

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 22, 2007
Pulmonary lymphomatoid granulomatosis in a renal allograft recipientR Joseph, B Chacko, M T Manipadam, et al.
Nephron|January 1, 1996
Renal functional reserve in kidney donors assessed in different settings using scintigraphyJ George, G T John, R Oommen, et al.
Journal of Postgraduate Medicine|November 15, 2006
A six-hour extrapolated sampling strategy for monitoring mycophenolic acid in renal transplant patients in the Indian subcontinentD H Fleming, B S Mathew, G T John, et al.
Transplantation Proceedings|June 27, 2003
Pre- and postrenal transplantation pharmacokinetics of cyclosporine microemulsionG S Talaulikar, G T John, R Selvakumar, et al.
The National Medical Journal of India|May 1, 1995
HLA phenotypes in Asians developing tuberculosis on dialysis or after renal transplantationG T John, K Murugesan, L Jeyaseelan, et al.
Transplantation|June 15, 1994
A double-blind randomized controlled trial of primary isoniazid prophylaxis in dialysis and transplant patientsG T John, P P Thomas, M Thomas, et al.
Transplantation|March 27, 1996
A time table for infections after renal transplantation in the tropicsG T John, A Date, C M Mathew, et al.
Kidney International|September 5, 2001
Risk factors for post-transplant tuberculosisG T John, V Shankar, A M Abraham, et al.
The Journal of the Association of Physicians of India|April 25, 2000
Prognostic factors in diffuse proliferative lupus nephritisM A Abraham, A Korula, K Jayakrishnan, et al.
Transplantation Proceedings|February 20, 2003
Efficacy and safety of low-dose ketoconazole (50 mg) to reduce the cost of cyclosporine in renal allograft recipientsM A Abraham, P P Thomas, G T John, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 22, 2007
Pulmonary lymphomatoid granulomatosis in a renal allograft recipientR Joseph, B Chacko, M T Manipadam, et al.
Nephron|January 1, 1996
Renal functional reserve in kidney donors assessed in different settings using scintigraphyJ George, G T John, R Oommen, et al.
Journal of Postgraduate Medicine|November 15, 2006
A six-hour extrapolated sampling strategy for monitoring mycophenolic acid in renal transplant patients in the Indian subcontinentD H Fleming, B S Mathew, G T John, et al.
Transplantation Proceedings|June 27, 2003
Pre- and postrenal transplantation pharmacokinetics of cyclosporine microemulsionG S Talaulikar, G T John, R Selvakumar, et al.
The National Medical Journal of India|May 1, 1995
HLA phenotypes in Asians developing tuberculosis on dialysis or after renal transplantationG T John, K Murugesan, L Jeyaseelan, et al.
Transplantation|June 15, 1994
A double-blind randomized controlled trial of primary isoniazid prophylaxis in dialysis and transplant patientsG T John, P P Thomas, M Thomas, et al.
Transplantation|March 27, 1996
A time table for infections after renal transplantation in the tropicsG T John, A Date, C M Mathew, et al.
Kidney International|September 5, 2001
Risk factors for post-transplant tuberculosisG T John, V Shankar, A M Abraham, et al.
The Journal of the Association of Physicians of India|April 25, 2000
Prognostic factors in diffuse proliferative lupus nephritisM A Abraham, A Korula, K Jayakrishnan, et al.
Transplantation Proceedings|February 20, 2003
Efficacy and safety of low-dose ketoconazole (50 mg) to reduce the cost of cyclosporine in renal allograft recipientsM A Abraham, P P Thomas, G T John, et al.
Pageof 7